Results from further evaluations using hPBMCs revealed that 9h could augment the IL-2 secretion and reverse the PGE2-induced immune suppression. Taken together, our study on these quinazoline-2,5-diamine derivatives provided not only an in vitro tool for the community to better understand the HPK1 pharmacology, but also a reliable reference for the later development of HPK1 inhibitors.